A Web Site and Print Materials Intervention for Smoking Intervention for Childhood and Young Adult Cancer Survivors

Not Applicable

Completed

• Conditions: Cancer
• Interventions: Other: Web Intervention; Behavioral: print materials

• Registration Number: NCT00588107
• Lead Sponsor: Dana-Farber Cancer Institute

Brief Summary

The purpose of this study was to compare two different ways of helping people who have had childhood cancer, leukemia, tumors or similar illnesses learn health information and information about trying to quit smoking. All participants received materials in the mail about their health, survivorship, and smoking. Some participants were also invited to use a website. The goal of the study was to see which is a better way to get information about health issues, survivorship, and smoking.

Detailed Description

The study was a randomized controlled trial with two groups. It was designed to demonstrate the efficacy and cost-effectiveness of a Web-based format of the PFH intervention, compared to a written Materials control condition. The study was conducted among childhood and young adult cancer survivors, who smoke, at four survivor clinics. Participants in both conditions received access to pharmacotherapy at no cost. Participants in the Web condition received access to an interactive Web site that focuses on survivorship, health, and smoking.

Participants in the Web condition received access to an interactive Web site that focuses on survivorship, health, and smoking. Participants in the Materials control group received tailored and targeted print materials.

Study Timeline

• Study Start: 2005-09
• Study First Submitted: 2007-12-24
• Study First Submitted QC: 2008-01-07
• Study First Posted: 2008-01-08
• Primary Completion: 2010-10
• Study Completion: 2013-12
• Status Verified: 2014-12
• Last Update Submitted: 2014-12-30
• Last Update Posted: 2014-12-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 374

Inclusion Criteria

• Have been diagnosed with cancer before age 35
• Currently be ≥ 18 years of age and ≤ 55 years of age
• 2 or more years out of cancer treatment
• Be mentally capable of providing informed consent
• Be reachable by telephone for screening and survey completion
• Be a current smoker (defined as having taken one puff of a cigarette in the last 30 days)
• Fluent in English

Read More

Exclusion Criteria

• Currently undergoing active treatment for cancer

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Web site access	Web Intervention	Web intervention- and access to pharmacotherapy
print materials	print materials	Receives tailored print materials and access to pharmacotherapy (Materials condition)

Primary Outcome Measures

Name	Time	Method
The primary outcome is smoking cessation	15 months post BL

Secondary Outcome Measures

Name	Time	Method
Secondary outcome: cost-effectiveness, intervention dose delivered, reach, impact, quit attempts, motivation to quit, and use of pharmacotherapy	15 months post BL

Trial Locations

Locations (1)

DFCI; 🇺🇸 Boston, Massachusetts, United States